UROTHELIAL CARCINOMA BLADDER
Clinical trials for UROTHELIAL CARCINOMA BLADDER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA BLADDER trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New bladder cancer drug shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called UGN-301 (zalifrelimab) in 51 people with recurrent non-muscle invasive bladder cancer. The goal was to check the drug's safety and find the best dose when given directly into the bladder, alone or with other treatments. Results will…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 26, 2026 10:18 UTC
-
New combo aims to unleash immune system on tough cancers
Disease control CompletedThis early-phase study tested whether adding L-NMMA to the immunotherapy drug pembrolizumab is safe for people with several advanced cancers, including melanoma, lung cancer, and others. The goal was to see if blocking a signal that protects cancer cells could help the immune sys…
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 26, 2026 10:13 UTC
-
New drug cocktail shows promise for three tough cancers
Disease control CompletedThis study tested a combination of two drugs (IO102-IO103 and pembrolizumab) as the first treatment for people with advanced lung, head & neck, or bladder cancer that has spread. The goal was to see if the combo could shrink tumors and delay cancer growth. A total of 63 patients …
Matched conditions: UROTHELIAL CARCINOMA BLADDER
Phase: PHASE2 • Sponsor: IO Biotech • Aim: Disease control
Last updated May 26, 2026 08:19 UTC